Track the Vicore Pharma Holding AB share price and the full insider trade history of the company, a listed issuer based in Finland. Shares are quoted on FI FI, under the oversight of FIN-FSA. Operating in the Health Care sector, Vicore Pharma Holding AB has published 0 insider filings. Market capitalisation: €3.2bn. Every trade is accessible without an account.
Analysts rate Vicore Pharma Holding AB Strong Buy (bullish), based on 6 analysts. Average price target: SEK 29.50.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
0 of 0 declarations
Vicore Pharma Holding AB is a Swedish biopharmaceutical company focused on developing treatments for respiratory diseases. It is listed on the Stockholm Stock Exchange (XSTO).